[ad_1] Steven McIntoshEntertainment reporterGetty ImagesThe closing credits of 2021's No Time To Die, the most recent film in the 007 series, ended with a familiar message: "James Bond will return."But for the last few years,…
Who is Ahmad al-Sharaa? Islamist rebel leader named…
[ad_1] File photo: Syrian interim President Ahmad al-Sharaa (Picture credit: AP) Ahmad al-Sharaa, formerly known as Abu Mohammed al-Jolani, emerged as Syria’s interim president on Wednesday, after leading the offensive that toppled Bashar al-Assad’s government…
Leader of rebels who toppled Syrian President Bashar…
[ad_1] FILE - Syria's de facto leader Ahmad al-Sharaa, formerly known as Abu Mohammed al-Golani, walks in the presidential palace ahead of his meeting with Walid Ellafi, Libyan minister of state for communication and political…
Coal India declares second interim dividend post Q3…
[ad_1] Stock Market Today: Coal India on Monday along with its financial performance also declared a second interim dividend of ₹5.60 per share: Check Details hereStock Markets today: Coal India declares interim dividendStock Market Today:…
Shriram Finance dividend: NBFC declares second interim dividend…
[ad_1] Shriram Finance dividend: The Non-banking financial services (NBFC) firm, Shriram Finance Ltd, announced its second interim dividend issue for the financial year 2024-25, at ₹2.50 per equity share of a face value of ₹2…
Torrent Pharma Q3 results: Net profit rises 14%…
[ad_1] Torrent Pharma Q3 results: Net profit rises 14% YoY to ₹503 cr; Firm declares interim dividend of ₹26 per shareTorrent Pharma Q3 results: Torrent Pharmaceuticals announced their third-quarter results on January 24. (iStock)Torrent Pharma…
Nestle India declares Q3 results 2025 date, sets…
[ad_1] Nestle India declares Q3 results 2025 date, sets record date for second interim dividend [ad_2] Live Mint
Shriram Finance Q3 Results: Net profit jumps 96.3%…
[ad_1] Shriram Finance on Friday reported an 96.3% year-on-year rise in its net profit for the fiscal's third quarter ended December (Q3FY25) to ₹3,569.76 crore. The company had reported a profit of ₹1,818.33 crore in…
Dr Lal PathLabs sets board meeting date to…
[ad_1] Dr Lal PathLabs Q3 results date: Diagnostics company Dr Lal PathLabs is slated to meet next to consider and approve its financial results for the quarter ended December 30, 2024 (Q3), the company informed…